Abstract
Ankylosing spondylitis (AS) and other forms of seronegative spondylarthritis (SpA) are characterized by two major processes in joints—the first is chronic inflammation and the second is progressive ankylosis. Both features go hand-in-hand and determine the clinical picture of disease, which is joint pain, progressive stiffness and, in case of peripheral joint involvement also joint swelling. The interplay between inflammation and ankylosis is best illustrated in AS, where chronic inflammation of the spine leads to progressive stiffness, reduced spinal mobility and kyphosis. AS may thus be considered as a synthesis of inflammatory disease and bone disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Braun J, Landewé R, Hermann KG et al. Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study. Arthritis Rheum 2006; 54:1646–52.
Davis J, van der Heijde D, Braun J et al. Recombinant human tumor necrosis factor receptor (Etanercept) for treating ankylosing spondylitis A randomized, controlled trial. Arthritis Rheum 2003; 48:3230–6
van der Heijde D, Kivitz A, Schiff M et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2006:54:2136–2.
Schett G, Landewé R, Desiree van der Heijde D. TNF blockers and structural remodeling in ankylosing spondylitis-what is reality and what is fiction? Ann Rheum Dis 2007; 66:709–11.
Schett G, Redlich K, Smolen JS. Inflammation-induced bone loss in the rheumatic diseases. In: Favus MJ, Ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 6th Edition. Washington D.C.: ASBMR, 2006; 6:310–313.
Gravallese EM, Harada Y, Wang JT et al. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 1998; 152:943–951.
Boers M, Kostense PJ, Verhoeven AC et al. Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis. Arthritis Rheum 2001; 44:2242–6.
Scott DL, Pugner K, Kaarela K et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) 2000; 39:122–132.
Storm EE, Kingsley DM. Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development 1996; 122:3969–79.
Hartmann C, Tabin CJ. Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell 2001; 104:341–51.
Benjamin M, McGonagle D. The anatomical basis for disease localization in seronegative spondylar-thropathy at entheses and related sites. J Anat 2001; 199:503–526.
Ball J. Enthesopathy of rheumatoid and ankylosing spondylitis. Ann Rheum Dis 1971; 30(3):213–23.
Lories RJ, Derese I, Luyten FP. Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis. J Clin Invest 2005; 115:1571–9.
Appel H, Kuhne M, Spiekermann S et al. Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 2006; 54(9):2845–51.
Scharstuhl A, Vitters EL, van der Kraan PM et al. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum 2003; 48:3442–51.
Lories RJ, Derese I, de Bari C et al. Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis. Arthritis Rheum 2007; 56(2):489–97.
Lories RJ, Matthys P, de Vlam K et al. Ankylosing enthesitis, dactylitis and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis. Ann Rheum Dis 2004; 63(5):595–8.
Miller JR. The Wnts. Genome Biol 2002; 3(1):3001.
Diarra D, Stolina M, Polzer K et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007; 13:156–163.
Lories R, Peeters J, Bakker A et al. Deletion of Frzb affects articular cartilage and biomechanical poperties of the long bones. Arthritis Rheum 2007, in press.
McInnes I, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Immunol 2007; 7:429–442.
Gough AK, Lilley J, Eyre S et al. Generalized bone loss in patients with early rheumatoid arthritis. Lancet 1994; 344:23–27.
Ralston SH, Urquhart GD, Brzeski M et al. Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ 1990; 300:563–565.
Schett G, Kiechl S, Weger S et al. High-sensitivity C-reaktive protein and risk of nontraumatic fractures in the bruneck study. Arch Int Med 2006; 166:2495–501.
Appel H, Loddenkemper C, Grozdanovic Z et al. Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 2006; 22:R143.
Jimenez-Boj E, Nobauer-Huhmann I, Hanslik-Schnabel B et al. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum 2007; 56:1118–24.
Gortz B, Hayer S, Redlich K et al. Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation. J Bone Miner Res 2004; 19(6):990–8.
Glass DA, Bialek P, Ahn JD et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 2005; 8:751–64.
van der Heijde DM, Landewé RB, Ory P et al. Two-year etanercept therapy does not inhibit radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis 2006; 65(Suppl II):81.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Schett, G. (2009). Bone Formation Versus Bone Resorption in Ankylosing Spondylitis. In: López-Larrea, C., Díaz-Peña, R. (eds) Molecular Mechanisms of Spondyloarthropathies. Advances in Experimental Medicine and Biology, vol 649. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0298-6_8
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0298-6_8
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0297-9
Online ISBN: 978-1-4419-0298-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)